Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tampere Coronary Artery Disease and Sudden Cardiac Arrest Study

NCT06804499 is registered in ClinicalTrials.gov with Tampere Heart Hospital as lead sponsor.

NCT NCT06804499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06804499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tampere Coronary Artery Disease and Sudden Cardiac Arrest Study
Lead sponsor
Tampere Heart Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 13, 2025
Completion date
December 31, 2042
Enrollment
4,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary event, coronary arterial disease (cad), sudden cardiac arrest, sudden cardiac death, sudden cardiac death due to cardiac arrhythmia